Adenosine A2A-receptor stimulation inhibits lipopolysaccharide- induced interleukin-18 production in monocytes

Journal of Pharmacological Sciences

Volumn 104, Issue 2, 2007, Pages 183-186

  Takahashi, Hideo Kohka ^a   Kanke, Toru ^a   Liu, Keyue ^a   Yoshino, Tadashi ^a   Sendo, Toshiaki ^a   Tanaka, Noriaki ^a   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adenosine; Interleukin 18; Monocyte

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; PROTEIN KINASE INHIBITOR; ADENOSINE;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MONOCYTE; BIOSYNTHESIS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IC 50; METABOLISM; PHYSIOLOGY;

ADENOSINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTOR, ADENOSINE A2A;

EID: 34250830183     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.SC0070101     Document Type: Article

References (15)

1. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;13:227-242.
2. Takahashi HK, Iwagaki H, Mori S, Yoshino T, Tanaka N, Nishibori M. Prostaglandins E1 and E2 inhibit lipopolysaccharide-induced interleukin-18 production in monocytes. Eur J Pharmacol. 2005;517:252-256.
3. Schumann RR, Belka C, Reuter D, Lamping N, Kirschning CJ, Weber JR, et al. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood. 1998;91:577-584.
4. Netea MG, Fantuzzi G, Kullberg BJ, Stuyt RJL, Pulido EJ, Mcintyre RC, et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol. 2000;164:2644-2649.
5. Nakamura S, Otani T, Ijiri Y, Motoda R, Kurimoto M, Orita K. IFN-γ-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. J Immunol. 2000;164:3330-3336.
6. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414:916-920.
7. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996;27:1697-1702.
8. Sullivan GW, Fang G, Linden J, Scheld WM. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis. 2004;189:1897-1904.
9. Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, Lysenko L, et al. Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock. Shock. 2007;27:25-31.
10. 2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol. 2006;176:5616-5626.
11. Takahashi HK, Iwagaki H, Tamura R, Xue D, Sano M, Mori S, et al. Unique regulation profile of prostaglandin E1 on adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther. 2003;307:1188-1195.
12. Zhang JG, Hepburn L, Cruz G, Borman RA, Clark KL. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. Biochem Pharmacol. 2005;69:883-889.
13. 2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol. 2002;72:1027-1036.
14. Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, et al. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol. 2000;164:436-442.
15. Takahashi HK, Iwagaki H, Mori S, Yoshino T, Tanaka N, Nishibori M. Histamine inhibits lipopolysuccalide-induced interleukin (IL)-18 production in human monocytes. Clin Immunol. 2004;112:30-34.